|
---|
Category:Letter type:NLS
MONTHYEARNLS2024006, Response to Nuclear Regulatory Commission'S Request for Additional Information for Relief Request RC3-022024-01-25025 January 2024 Response to Nuclear Regulatory Commission'S Request for Additional Information for Relief Request RC3-02 NLS2024007, Emergency Plan Implementing Procedure 5.7.1, Revision 732024-01-16016 January 2024 Emergency Plan Implementing Procedure 5.7.1, Revision 73 NLS2024003, 30 Day Report - Unauthorized Disassembly of Liquid Scintillation Detector2024-01-15015 January 2024 30 Day Report - Unauthorized Disassembly of Liquid Scintillation Detector NLS2024004, Annual Report of Changes and Errors in Emergency Core Cooling System Evaluation Models for 20232024-01-10010 January 2024 Annual Report of Changes and Errors in Emergency Core Cooling System Evaluation Models for 2023 NLS2023053, ISFSI, Supplement to Exemption Request from Enhanced Weapons, Firearms Background Checks, and Security Event Notifications Implementation2023-11-30030 November 2023 ISFSI, Supplement to Exemption Request from Enhanced Weapons, Firearms Background Checks, and Security Event Notifications Implementation NLS2023050, Request for Exemption from Enhanced Weapons, Firearms Background Checks, and Security Event Notifications Implementation2023-11-22022 November 2023 Request for Exemption from Enhanced Weapons, Firearms Background Checks, and Security Event Notifications Implementation NLS2023045, Application to Revise Technical Specifications to Adopt TSTF-374, Revision to Diesel Fuel Oil Testing Program2023-11-15015 November 2023 Application to Revise Technical Specifications to Adopt TSTF-374, Revision to Diesel Fuel Oil Testing Program NLS2023051, Response to Nuclear Regulatory Commission Request for Additional Information Regarding Application to Revise Technical Specifications to Adopt TSTF-551, Revise Secondary Containment Surveillance Requirements2023-10-10010 October 2023 Response to Nuclear Regulatory Commission Request for Additional Information Regarding Application to Revise Technical Specifications to Adopt TSTF-551, Revise Secondary Containment Surveillance Requirements NLS2023049, 10 CFR Part 21 Report Regarding HGA Relays2023-09-0606 September 2023 10 CFR Part 21 Report Regarding HGA Relays NLS2023029, License Amendment Request to Revise Technical Specifications to Support Inspection of Diesel Fuel Oil Storage Tanks2023-09-0606 September 2023 License Amendment Request to Revise Technical Specifications to Support Inspection of Diesel Fuel Oil Storage Tanks NLS2023047, Licensee Guarantees of Payment of Deferred Premiums2023-07-26026 July 2023 Licensee Guarantees of Payment of Deferred Premiums NLS2023033, 10 CFR 50.55a Relief Request RC3-022023-06-27027 June 2023 10 CFR 50.55a Relief Request RC3-02 NLS2023039, Preparation and Scheduling of Operator Licensing Examinations2023-06-0101 June 2023 Preparation and Scheduling of Operator Licensing Examinations NLS2023038, Nebraska Public Power District 2022 Financial Report2023-05-22022 May 2023 Nebraska Public Power District 2022 Financial Report NLS2023031, Annual Radiological Environmental Report2023-05-11011 May 2023 Annual Radiological Environmental Report NLS2023017, Application to Revise Technical Specifications to Adopt TSTF-551, Revise Secondary Containment Surveillance Requirements2023-05-0303 May 2023 Application to Revise Technical Specifications to Adopt TSTF-551, Revise Secondary Containment Surveillance Requirements NLS2023018, Application to Revise Technical Specifications to Adopt TSTF-580, Provide Exception from Entering Mode 4 with No Operable RHR Shutdown Cooling2023-05-0303 May 2023 Application to Revise Technical Specifications to Adopt TSTF-580, Provide Exception from Entering Mode 4 with No Operable RHR Shutdown Cooling NLS2023030, Annual Radioactive Effluent Release Report2023-04-27027 April 2023 Annual Radioactive Effluent Release Report NLS2023007, Technical Specification Bases Changes2023-04-17017 April 2023 Technical Specification Bases Changes NLS2023027, Annual Report of Individual Exposure Monitoring2023-04-13013 April 2023 Annual Report of Individual Exposure Monitoring NLS2023021, Quality Assurance Program Changes2023-04-10010 April 2023 Quality Assurance Program Changes NLS2023020, Decommissioning Funding2023-03-29029 March 2023 Decommissioning Funding NLS2023019, Property Insurance Coverage2023-03-23023 March 2023 Property Insurance Coverage NLS2023010, Inservice Inspection OAR-1 Owner'S Activity Report for Cooper Nuclear Station2023-02-0909 February 2023 Inservice Inspection OAR-1 Owner'S Activity Report for Cooper Nuclear Station NLS2023005, Annual Report of Changes and Errors in Emergency Core Cooling System Evaluation Models for 20222023-01-19019 January 2023 Annual Report of Changes and Errors in Emergency Core Cooling System Evaluation Models for 2022 NLS2022054, Preparation and Scheduling of Operator Licensing Examinations2023-01-0505 January 2023 Preparation and Scheduling of Operator Licensing Examinations NLS2022055, Emergency Plan, Revision 812023-01-0404 January 2023 Emergency Plan, Revision 81 NLS2022053, CNS-2022-11 Post Exam Submittal2022-11-22022 November 2022 CNS-2022-11 Post Exam Submittal NLS2022050, Notification of Revision to Cooper Nuclear Station Emergency Response Data System Data Point Library2022-11-0909 November 2022 Notification of Revision to Cooper Nuclear Station Emergency Response Data System Data Point Library NLS2022048, Management Change and Correspondence Update2022-11-0101 November 2022 Management Change and Correspondence Update NLS2022047, Core Operating Limits Report, Cycle 33, Revision 02022-10-14014 October 2022 Core Operating Limits Report, Cycle 33, Revision 0 NLS2022042, 10 CFR 50.59(d)(2) and 10 CFR 72.48(d)(2) Summary Report2022-10-0707 October 2022 10 CFR 50.59(d)(2) and 10 CFR 72.48(d)(2) Summary Report NLS2022037, Emergency Plan, Revision 80, Summary of 50.54(q) Analyses2022-08-18018 August 2022 Emergency Plan, Revision 80, Summary of 50.54(q) Analyses NLS2022035, Evacuation Time Estimate Report for Cooper Nuclear Station2022-08-16016 August 2022 Evacuation Time Estimate Report for Cooper Nuclear Station NLS2022031, Licensee Guarantees of Payment of Deferred Premiums2022-07-19019 July 2022 Licensee Guarantees of Payment of Deferred Premiums NLS2022005, Application to Revise Technical Specifications to Adopt TSTF-554, Revision 1, Revise Reactor Coolant Leakage Requirements2022-06-16016 June 2022 Application to Revise Technical Specifications to Adopt TSTF-554, Revision 1, Revise Reactor Coolant Leakage Requirements NLS2022025, Nebraska Public Power District Letter (NLS2022010) to U.S. Nuclear Regulatory Commission Dated April 5, 2022, Annual Report of Individual Exposure Monitoring2022-06-0606 June 2022 Nebraska Public Power District Letter (NLS2022010) to U.S. Nuclear Regulatory Commission Dated April 5, 2022, Annual Report of Individual Exposure Monitoring NLS2022016, Annual Radiological Environmental Report2022-05-10010 May 2022 Annual Radiological Environmental Report NLS2022020, Nebraska Public Power District, Cooper Nuclear Station, 2021 Financial Report2022-05-0202 May 2022 Nebraska Public Power District, Cooper Nuclear Station, 2021 Financial Report NLS2022014, Annual Radioactive Effluent Release Report2022-04-27027 April 2022 Annual Radioactive Effluent Release Report NLS2022010, Annual Report of Individual Exposure Monitoring2022-04-0505 April 2022 Annual Report of Individual Exposure Monitoring NLS2022009, Property Insurance Coverage2022-03-23023 March 2022 Property Insurance Coverage NLS2022011, Preparation and Scheduling of Operator Licensing Examinations2022-03-18018 March 2022 Preparation and Scheduling of Operator Licensing Examinations NLS2022004, Response to Nuclear Regulatory Commission'S Request for Additional Information Regarding Relief Request RR5-01, Revision 12022-02-0707 February 2022 Response to Nuclear Regulatory Commission'S Request for Additional Information Regarding Relief Request RR5-01, Revision 1 NLS2022003, Annual Report of Changes and Errors in Emergency Core Cooling System Evaluation Models for 20212022-01-20020 January 2022 Annual Report of Changes and Errors in Emergency Core Cooling System Evaluation Models for 2021 NLS2021067, ISFSI - Independent Spent Fuel Storage Installation Decommissioning Funding Plan2021-12-16016 December 2021 ISFSI - Independent Spent Fuel Storage Installation Decommissioning Funding Plan NLS2021069, Withdrawal of Application to Revise Technical Specifications to Adopt TSTF-551, Revise Secondary Containment Surveillance Requirements2021-12-15015 December 2021 Withdrawal of Application to Revise Technical Specifications to Adopt TSTF-551, Revise Secondary Containment Surveillance Requirements NLS2021066, Response to Nuclear Regulatory Commission'S Request for Additional Information Regarding Alternative Request RI5-02, Revision 32021-12-10010 December 2021 Response to Nuclear Regulatory Commission'S Request for Additional Information Regarding Alternative Request RI5-02, Revision 3 NLS2021065, Clarification of Response to Nuclear Regulatory Commission'S Request for Additional Information for Alternative Request RS-012021-12-0606 December 2021 Clarification of Response to Nuclear Regulatory Commission'S Request for Additional Information for Alternative Request RS-01 NLS2021056, Application to Revise Technical Specifications to Adopt TSTF-551, Revise Secondary Containment Surveillance Requirements2021-11-16016 November 2021 Application to Revise Technical Specifications to Adopt TSTF-551, Revise Secondary Containment Surveillance Requirements 2024-01-25
[Table view] Category:License-Fitness for Duty (FFD) Performance Report
MONTHYEARML23059A3032023-02-28028 February 2023 Single Positive Test Form Collected on 9/26/2022 ML23059A3072023-02-28028 February 2023 Single Positive Test Form Collected on 09/30/2022 ML23059A2982023-02-28028 February 2023 Annual Report Form for Drug and Alcohol Tests for 2022 ML23059A3012023-02-28028 February 2023 Single Positive Test Form Collected on 04/25/2022 ML23059A2992023-02-28028 February 2023 Annual Fatigue Report Form for 2022 ML23059A3022023-02-28028 February 2023 Single Positive Test Form Collected on 09/26/2022 ML23059A3042023-02-28028 February 2023 Single Positive Test Form Collected on 09/26/2022 ML23059A3082023-02-28028 February 2023 Single Positive Test Form Collected on 10/03/2022 ML23059A3052023-02-28028 February 2023 Single Positive Test Form Collected on 09/28/2022 ML23059A3002023-02-28028 February 2023 Single Positive Test Form Collected on 04/18/2022 ML22047A1442022-02-16016 February 2022 Annual Fatigue Report Form for 2020 ML22047A1392022-02-16016 February 2022 Annual Report Form for Drug and Alcohol Tests for 2021 ML22047A1382022-02-16016 February 2022 Annual Fatigue Report Form for 2021 ML22047A1402022-02-16016 February 2022 Single Positive Test Form Collected on 08/31/2021 ML21049A1582021-02-18018 February 2021 Single Positive Test Form Collected on 09/08/2020 ML21049A1632021-02-18018 February 2021 Annual Fatigue Report Form for 2020 ML21049A1622021-02-18018 February 2021 Single Positive Test Form Collected on 11/18/2020 ML21049A1612021-02-18018 February 2021 Single Positive Test Form Collected on 10/11/2020 ML21049A1592021-02-18018 February 2021 Single Positive Test Form Collected on 09/24/2020 ML21049A1572021-02-18018 February 2021 Annual Report Form for Drug and Alcohol Tests for 2020 ML20044E5932020-02-13013 February 2020 Annual Fatigue Report Form for 2019 ML20044E5942020-02-13013 February 2020 Annual Report Form for Drug and Alcohol Tests for 2019 ML20044E5952020-02-13013 February 2020 Single Positive Test Form Collected on 06/03/2019 ML20044E5962020-02-13013 February 2020 Single Positive Test Form Collected on 08/21/2019 ML19051A0772019-02-20020 February 2019 Annual Report Form for Drug and Alcohol Tests for 2018 ML19049A0032019-02-18018 February 2019 Annual Fatigue Report Form for 2018 ML19049A0052019-02-18018 February 2019 Single Positive Test Form Collected on 08/23/2018 ML19049A0042019-02-18018 February 2019 Single Positive Test Form Collected on 01/12/2018 ML19049A0062019-02-18018 February 2019 Single Positive Test Form Collected on 09/18/2018 ML19049A0072019-02-18018 February 2019 Single Positive Test Form Collected on 09/22/2018 ML19049A0082019-02-18018 February 2019 Single Positive Test Form Collected on 10/06/2018 ML19049A0092019-02-18018 February 2019 Single Positive Test Form Collected on 10/15/2018 ML19049A0102019-02-18018 February 2019 Annual Report Form for Drug and Alcohol Tests for 2018 NLS2017053, Submittal of 30-Day Report Per 10 CFR 26.719(c), Blind Performance Testing2017-06-0202 June 2017 Submittal of 30-Day Report Per 10 CFR 26.719(c), Blind Performance Testing ML17055A4422017-02-24024 February 2017 Single Positive Test Form Collected on 09/07/2016 ML16043A0132016-02-12012 February 2016 Single Positive Test Form Collected on 01/26/2015 ML16043A0142016-02-12012 February 2016 Single Positive Test Form Collected on 02/27/2015 ML16043A0102016-02-12012 February 2016 Annual Fatigue Report Form for 2015 ML16043A0122016-02-12012 February 2016 Annual Report Form for Drug and Alcohol Tests for 2015 ML15044A3712015-02-13013 February 2015 Single Positive Test Form Collected on 05/13/2014 ML15044A3762015-02-13013 February 2015 Single Positive Test Form Collected on 06/16/2014 ML15044A3752015-02-13013 February 2015 Annual Report Form for Drug and Alcohol Tests for 2014 ML15044A3742015-02-13013 February 2015 Single Positive Test Form Collected on 09/25/2014 ML15044A3732015-02-13013 February 2015 Single Positive Test Form Collected on 09/17/2014 ML15044A3722015-02-13013 February 2015 Annual Fatigue Report for 2014 ML14056A0072014-02-17017 February 2014 Annual Reporting Form for Drug and Alcohol Tests, for Calendar Year 2013 ML14056A0092014-02-13013 February 2014 CFR Part 26, Subpart I - Managing Fatigue, for Period Ending 2013 ML14056A0082014-02-13013 February 2014 Single Positive Test Form, for Random, Collected on 03/19/2013 ML14056A0062014-02-13013 February 2014 Single Positive Test Form, for Pre-Access, Collected on 05/22/2013 ML14056A0102014-02-10010 February 2014 Single Positive Test Form, for Random, Collected on 06/12/2013 2023-02-28
[Table view] |
Text
H Nebraska Public Power District 1
Always there when you need us NLS2017053 10 CFR 26.719(c)
June 2, 2017 U.S. Nuclear Regulatory Commission Document Control Desk Washington, D.C. 20555-0001
Subject:
Submittal of 30-Day Report per 10 CFR 26.719(c)
Cooper Nuclear Station, Docket No. 50-298, DPR-46
Dear Sir or Madam:
. In accordance with 10 CFR 26.719(c), "Drug and alcohol testing errors," Nebraska Public Power District is providing the attached report on an issue related to blind performance testing for Cooper Nuclear Station.
As required by 10 CFR 26. 719(c), this report is being submitted within 3 0 days of completing an investigation of any testing errors or unsatisfactory performance discovered in performance testing at either a licensee testing facility or a Health and Human Services (HHS)-certified laboratory, in the testing of quality control or actual specimens. This report does not pertain to an actual testing error, but rather to the makeup of blind performance test samples submitted to the HHS-certified laboratory. The investigation associated with this issue was completed on May 17, 2017. The attached report includes a description of the issue, investigation results, and associated corrective actions.
This letter contains no regulatory commitments.
Should you have any questions regarding this matter, please contact Jim Shaw, Licensing Manager, at (402) 825-2788.
Sin~
Ke~eth HiJnbotham Vice-President Nuclear and Chief Nuclear Officer
/lb
Attachment:
30-Day Report per 10 CFR 26.719(c)
COOPER NUCLEAR STATION PO Box 98 /Brownville, NE 68321-0098 Telephone: (402) 825-3811 /Fax: (402) 825-5211 wwwnppd.com
NLS2017053 Page 2 of2 cc: Regional Administrator w/attachment USNRC - Region IV Senior Resident Inspector w/attachment USNRC-CNS NPG Distribution w/attachment CNS Records w/attachment l
NLS2017053 Attachment Page 1 of2 30-Day Report per 10 CFR 26.719(c)
Description of Issue Cooper Nuclear Station (CNS) failed to submit positive blind performance test samples to the Health and Human Services (HHS)-certified laboratory for all drugs and drug metabolites that are required by 10 CFR 26. l 68(b). Specifically, for positive opiate specimens, CNS did not submit specimens that were positive for the opiate metabolites codeine and 6-acetylmorphine (6-AM) as required.
10 CFR 26.168(b) requires "Approximately 60 percent of the blind performance test samples submitted to the laboratory must be positive for one or more drugs or drug metabolites per sample and submitted so that all of the drugs for which the FFD program is testing are included at least once each calendar quarter.... "
Investigation On April 18, 2017, the CNS Fitness for Duty (FFD) staff was informed of an inspection finding at another utility regarding submittal of blind performance test samples. The issue specifically related to the failure to submit blind opiate specimens that were positive for each of the opiate metabolites.
The FFD staff reviewed CNS blind specimen submittals for the past three years and found that each positive blind specimen submitted for the opiate drug only contained positive metabolites for morphine. Blind specimens containing opiate metabolites for codeine and 6-AM were not provided to the HHS-certified laboratory.
This issue was limited to opiate metabolites. CNS has been meeting the requirement for the number of blind performance test samples for marijuana metabolites, cocaine metabolites, and amphetamines (amphetamines and methamphetamines).
The cause of this error was due to a differing interpretation of 10 CFR 26.168(b). The CNS FFD staff understood the regulation to require the submittal of blind performance test samples for each of the drugs that the FFD program tests for, rather than each of the drug metabolites.
The Medical Review Officer (MRO) for CNS was contacted regarding this issue and performed a review of the testing process for blind samples sent to the HHS-certified laboratory. He determined that blind samples that were positive for opiates were sent for testing as required and all did test positive for opiates (initial test) and morphine (confirmatory test). The MRO concluded that we would not have missed any positive opioid drug tests due to codeine or heroin as a result of testing only the opiate/morphine blind sample.
NLS2017053 Attachment Page 2 of2 Corrective Actions CNS entered the identified deficiency into the Corrective Action Program. The following actions have been taken or planned:
- The FFD staff identified a blind specimen provider used in the industry that can supply opiate blind specimens which are positive for morphine, codeine, and 6-AM and a Purchase Order has been initiated.
- A positive opiate blind performance sample has been ordered that is positive for all three required metabolites and will be sent to the HHS-certified laboratory upon its arrival at CNS.
- Security Services Procedure 2.0, FFD Program Implementation, and the FFD deskguide for blind specimen testing will be revised to reflect that blind performance samples for each drug and drug metabolite that CNS tests for will be submitted per the requirements in 10 CPR 26. l 68(b).